NFE2L2 and hepatocellular carcinoma: Overexpression of the NFE2L2 target gene NQO1 in tumors was significantly associated with metastasis, vascular invasion, and poor outcome [27], which indicated the mechanism underlying the higher NQO1 level causing poor outcomes in patients with HCC.